Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood

• Publication date

  2003-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2002-11-3387PMID 12515714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BCL6 Controls the Expression of the B7-1/CD80 Costimulatory Receptor in Germinal Center B Cells

  2003cited by this paper
• Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.

  2002cited by this paper
• The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: Implications for a role of BCL6 in the down-regulation of apoptosis

  2002cited by this paper
• Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B‐cell lymphoma

  2002cited by this paper
• Acetylation inactivates the transcriptional repressor BCL6

  2002cited by this paper
• Acetylation Inactivates the BCL6 Transcriptional Repressor

  2002cited by this paper
• Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.

  2002cited by this paper
• Arrested Differentiation, the Self-Renewing Memory Lymphocyte, and Vaccination

  2001cited by this paper
• Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.

  2001cited by this paper
• Rearrangements in Non-Hodgkin ' s Lymphoma : Correlation With Histology , Immunophenotype , Karyotype , and Clinical Outcome in 217 Patients

  2000cited by this paper
• Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.

  2000cited by this paper
• BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

  2000cited by this paper
• Engineering stability in gene networks by autoregulation

  2000cited by this paper
• Identification of negative regulatory regions within the first exon and intron of the BCL6 gene

  2000cited by this paper
• BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia.

  2000cited by this paper
• Analysis of internal deletions within the BCL6 gene in B‐cell non‐Hodgkin's lymphoma

  1999cited by this paper
• Transcriptional Repression of Stat6-Dependent Interleukin-4-Induced Genes by BCL-6: Specific Regulation of Iɛ Transcription and Immunoglobulin E Switching

  1999cited by this paper
• Nonimmunoglobulin gene hypermutation in germinal center B cells.

  1999cited by this paper
• Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation.

  1998cited by this paper
• BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci.

  1998cited by this paper
• Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.

  1998cited by this paper
• Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes.

  1998cited by this paper
• Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor.

  1998cited by this paper
• Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation

  1997cited by this paper
• Control of inflammation, cytokine expression, and germinal center formation by BCL-6.

  1997cited by this paper
• The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

  1997cited by this paper
• BCL-6 expression during B-cell activation.

  1996cited by this paper
• BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.

  1996cited by this paper
• Transcriptional repression by the proto-oncogene BCL-6.

  1996cited by this paper
• Internal DNA deletion within the BCL-6 gene on untranslocated chromosome in non-Hodgkin's lymphoma with 3q27 abnormality.

  1996cited by this paper
• BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.

  1995cited by this paper
• BCL-6 protein is expressed in germinal-center B cells.

  1995cited by this paper
• Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma.

  1995cited by this paper
• Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

  1995cited by this paper
• Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators

  1995cited by this paper
• Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma.

  1994cited by this paper
• Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.

  1994cited by this paper
• Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.

  1993cited by this paper
• LAZ3, a novel zinc–finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas

  1993cited by this paper
• Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.

  1993cited by this paper
• Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma.

  1993cited by this paper
• Negative autoregulation of c‐myc gene expression is inactivated in transformed cells.

  1990cited by this paper
• Negative autoregulation of c‐myc transcription.

  1990cited by this paper
• A 12-base-pair DNA motif that is repeated several times in metallothionein gene promoters confers metal regulation to a heterologous gene.

  1984cited by this paper

• Decoding the impact of nsSNP variants on BCL6 function through integrated computational analysis.

  2026cites this paper
• SVelfie: A method for discovering cancer drivers based on enrichment of likely functional structural variants

  2025cites this paper
• Relocalizing transcriptional kinases to activate apoptosis

  2024cites this paper
• The fifth edition of the WHO classification of mature B‐cell neoplasms: open questions for research

  2024cites this paper
• B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond

  2024cites this paper
• Delineating the mechanism of fragility at BCL6 breakpoint region associated with translocations in diffuse large B cell lymphoma

  2024cites this paper
• Interleukin-4 downregulates transcription factor BCL6 to promote memory B cell selection in germinal centers.

  2024cites this paper
• AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity.

  2024cites this paper
• Borrowing Transcriptional Kinases to Activate Apoptosis

  2023cites this paper
• Engineered BCL6 BTB Domain of the Bcl-2 Protein Family shows Dynamic Structural Behavior: Insights from Molecular Dynamics Simulations

  2023cites this paper
• Mouse models of diffuse large B cell lymphoma

  2023cites this paper
• IL-4 downregulates BCL6 to promote memory B cell selection in germinal centers

  2023cites this paper
• MYCN Amplifications and Metabolic Rewiring in Neuroblastoma

  2023cites this paper
• Triple Lymphoma and Transformation to Diffuse Large B-Cell Lymphoma Finding at the Time of Diagnosis

  2023cites this paper
• The landscape of somatic mutations in lymphoblastoid cell lines

  2023cites this paper
• The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells

  2023cites this paper
• Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma

  2023cites this paper
• Dimerization choice and alternative functions of ZBTB transcription factors

  2023cites this paper
• The germinal center in the pathogenesis of B cell lymphomas

  2023cites this paper
• Stochastic modeling of a gene regulatory network driving B cell development in germinal centers

  2023cites this paper
• Bcl6, Irf2, and Notch2 promote nonclassical monocyte development

  2023cites this paper
• Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis

  2022cites this paper
• Bcl-6-dependent risk stratification by nuclear expression of Peli1 in diffuse large B-cell lymphoma

  2022cites this paper
• Oral histone deacetylase inhibitor HBI-8000 (tucidinostat) in Japanese patients with relapsed or refractory non-Hodgkin’s lymphoma: phase I safety and efficacy

  2022cites this paper
• Typical Enhancers, Super-Enhancers, and Cancers

  2022influential citation
• Rewiring cancer drivers to activate apoptosis

  2022cites this paper
• The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress

  2022cites this paper
• BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia

  2022cites this paper
• BCL6, a key oncogene, in the placenta, pre-eclampsia and endometriosis

  2022cites this paper
• Super-enhancer hypermutation alters oncogene expression in B cell lymphoma

  2022cites this paper
• An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo.

  2021cites this paper
• Evaluation of BCL6 and SIRT1 as Non-Invasive Diagnostic Markers of Endometriosis

  2021cites this paper
• Mouse Models of Germinal Center Derived B-Cell Lymphomas

  2021cites this paper
• Prognostic impact of immunophenotyping of diffuse large B-cell lymphoma - a single-centre experience

  2021cites this paper
• STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer

  2021cites this paper
• Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection

  2021cites this paper
• Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis

  2021cites this paper
• Molecular insights into the pathogenesis of follicular lymphoma

  2021cites this paper
• GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice

  2021cites this paper
• Biology of Germinal Center B Cells Relating to Lymphomagenesis

  2021cites this paper
• Bcl6-Mediated Transcriptional Regulation of Follicular Helper T cells (TFH).

  2021cites this paper
• Pathogenesis and Pathology of Pediatric Lymphoma

  2021cites this paper
• Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.

  2021cites this paper
• BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors.

  2021cites this paper
• BCL6 BTB‐specific inhibitor reversely represses T‐cell activation, Tfh cells differentiation, and germinal center reaction in vivo

  2021cites this paper
• Ontogeny, Genetics, Molecular Biology and Classification of B and T cell Non-Hodgkin’s Lymphoma

  2020cites this paper
• Genetic and epigenetic determinants of diffuse large B-cell lymphoma

  2020cites this paper
• Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring

  2020cites this paper
• Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells

  2019cites this paper
• Epigenetic Programing of B-Cell Lymphoma by BCL6 and Its Genetic Deregulation

  2019cites this paper
• Chapter 7 Prognostic impact of germinal center – associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma

  2019cites this paper
• Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.

  2019cites this paper
• T Follicular Regulatory Cells Promote the Germinal Center Reaction and Allergic IgE Response While Repressing Abnormal Differentiation of T Follicular Helper Cells

  2019cites this paper
• Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.

  2019cites this paper
• Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia

  2019cites this paper
• Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma

  2019cites this paper
• Genetic alterations and their clinical implications in DLBCL

  2019cites this paper
• Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray.

  2019cites this paper
• Impaired CpG Demethylation in Common Variable Immunodeficiency Associates With B Cell Phenotype and Proliferation Rate

  2019cites this paper
• Molecular and cellular genetics of non-Hodgkin lymphoma: Diagnostic and prognostic implications.

  2019cites this paper
• Molecular pathogenesis of germinal center‐derived B cell lymphomas

  2019cites this paper
• Immunobiochemical Reconstruction of Influenza Lung Infection—Melanoma Skin Cancer Interactions

  2019cites this paper
• Zmiany genetyczne w chłoniaku rozlanym z dużych komórek B

  2019cites this paper
• Genetics of diffuse large B-cell lymphoma.

  2018cites this paper
• Immunobiochemical reconstruction of influenza lung infection - Melanoma skin cancer interactions

  2018cites this paper
• Regulation of the Development and Function of B Cells by ZBTB Transcription Factors

  2018cites this paper
• BCL6 as a therapeutic target for lymphoma

  2018cites this paper
• Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression

  2018cites this paper
• Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.

  2018cites this paper
• Pathology and Molecular Pathogenesis of DLBCL and Related Entities

  2018cites this paper
• Novel Traits, Flower Symmetry, and Transcriptional Autoregulation: New Hypotheses From Bioinformatic and Experimental Data

  2018cites this paper
• Transcribing malignancy: transcription-associated genomic instability in cancer

  2018cites this paper
• Overcoming TCF4-Driven BCR Signaling in Diffuse Large B-Cell Lymphoma

  2018cites this paper
• B cells turn on, tune in with LSD1

  2018cites this paper
• MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type

  2018cites this paper
• New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.

  2018cites this paper
• Repression of miR-31 by BCL 6 stabilizes the helper function of human follicular helper T cells

  2017cites this paper
• Targeted epigenetic repression of a lymphoma oncogene by sequence-specific histone modifiers induces apoptosis in DLBCL

  2017cites this paper
• Expression pattern of BIM, BCL-6, and c-MYC in adult B-cell acute lymphoblastic leukemia

  2017cites this paper
• Repression of miR-31 by BCL6 stabilizes the helper function of human follicular helper T cells

  2017cites this paper
• Expression Pattern of the BCL6 and ITM2B Proteins in Normal Human Brains and in Alzheimer Disease

  2017cites this paper
• AMP kinase promotes Bcl6 expression in both mouse and human T cells

  2017cites this paper
• Characterization of genomic alterations in CIITA and their functional and clinical implications in malignant lymphomas

  2017cites this paper
• An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation

  2017cites this paper
• Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6.

  2017cites this paper
• BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma

  2017cites this paper
• Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria

  2016cites this paper
• Loss of Dnmt3b accelerates MLL-AF9 leukemia progression

  2016cites this paper
• A New Therapeutic Era in GCB and ABC Diffuse Large B-cell Lymphoma Molecular Subtypes: A Cell of Origin-Driven Review.

  2016cites this paper
• PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas

  2016cites this paper
• Regulation of hematopoietic development by ZBTB transcription factors

  2016cites this paper
• Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists.

  2016cites this paper
• Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

  2016cites this paper
• SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6

  2016cites this paper
• A Network Model to Describe the Terminal Differentiation of B Cells

  2016cites this paper
• The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target

  2016cites this paper
• Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation

  2016cites this paper
• The role of CREBBP mutations in lymphoid malignancies

  2016cites this paper
• Regulatory mechanisms contributing to the homeostasis of normal and malignant hematopoietic cells

  2016cites this paper
• Kruppel-like Factor 6 Promotes Macrophage-mediated Inflammation by Suppressing B Cell Leukemia/Lymphoma 6 Expression*

  2016cites this paper